This indicates that leptin can utilize multiple pathways to influence cancer cell migration, although we showed that in ovarian cancer cells inhibition of the JAK2/STAT3 pathway was sufficient to block this effect. This evidence concerns the gene JAK2 and ovarian carcinoma.